Cargando…
Lung microbiota across age and disease stage in cystic fibrosis
Understanding the significance of bacterial species that colonize and persist in cystic fibrosis (CF) airways requires a detailed examination of bacterial community structure across a broad range of age and disease stage. We used 16S ribosomal RNA sequencing to characterize the lung microbiota in 26...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431465/ https://www.ncbi.nlm.nih.gov/pubmed/25974282 http://dx.doi.org/10.1038/srep10241 |
_version_ | 1782371356771352576 |
---|---|
author | Coburn, Bryan Wang, Pauline W. Diaz Caballero, Julio Clark, Shawn T. Brahma, Vijaya Donaldson, Sylva Zhang, Yu Surendra, Anu Gong, Yunchen Elizabeth Tullis, D. Yau, Yvonne C. W. Waters, Valerie J. Hwang, David M. Guttman, David S. |
author_facet | Coburn, Bryan Wang, Pauline W. Diaz Caballero, Julio Clark, Shawn T. Brahma, Vijaya Donaldson, Sylva Zhang, Yu Surendra, Anu Gong, Yunchen Elizabeth Tullis, D. Yau, Yvonne C. W. Waters, Valerie J. Hwang, David M. Guttman, David S. |
author_sort | Coburn, Bryan |
collection | PubMed |
description | Understanding the significance of bacterial species that colonize and persist in cystic fibrosis (CF) airways requires a detailed examination of bacterial community structure across a broad range of age and disease stage. We used 16S ribosomal RNA sequencing to characterize the lung microbiota in 269 CF patients spanning a 60 year age range, including 76 pediatric samples from patients of age 4–17, and a broad cross-section of disease status to identify features of bacterial community structure and their relationship to disease stage and age. The CF lung microbiota shows significant inter-individual variability in community structure, composition and diversity. The core microbiota consists of five genera - Streptococcus, Prevotella, Rothia, Veillonella and Actinomyces. CF-associated pathogens such as Pseudomonas, Burkholderia, Stenotrophomonas and Achromobacter are less prevalent than core genera, but have a strong tendency to dominate the bacterial community when present. Community diversity and lung function are greatest in patients less than 10 years of age and lower in older age groups, plateauing at approximately age 25. Lower community diversity correlates with worse lung function in a multivariate regression model. Infection by Pseudomonas correlates with age-associated trends in community diversity and lung function. |
format | Online Article Text |
id | pubmed-4431465 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-44314652015-05-22 Lung microbiota across age and disease stage in cystic fibrosis Coburn, Bryan Wang, Pauline W. Diaz Caballero, Julio Clark, Shawn T. Brahma, Vijaya Donaldson, Sylva Zhang, Yu Surendra, Anu Gong, Yunchen Elizabeth Tullis, D. Yau, Yvonne C. W. Waters, Valerie J. Hwang, David M. Guttman, David S. Sci Rep Article Understanding the significance of bacterial species that colonize and persist in cystic fibrosis (CF) airways requires a detailed examination of bacterial community structure across a broad range of age and disease stage. We used 16S ribosomal RNA sequencing to characterize the lung microbiota in 269 CF patients spanning a 60 year age range, including 76 pediatric samples from patients of age 4–17, and a broad cross-section of disease status to identify features of bacterial community structure and their relationship to disease stage and age. The CF lung microbiota shows significant inter-individual variability in community structure, composition and diversity. The core microbiota consists of five genera - Streptococcus, Prevotella, Rothia, Veillonella and Actinomyces. CF-associated pathogens such as Pseudomonas, Burkholderia, Stenotrophomonas and Achromobacter are less prevalent than core genera, but have a strong tendency to dominate the bacterial community when present. Community diversity and lung function are greatest in patients less than 10 years of age and lower in older age groups, plateauing at approximately age 25. Lower community diversity correlates with worse lung function in a multivariate regression model. Infection by Pseudomonas correlates with age-associated trends in community diversity and lung function. Nature Publishing Group 2015-05-14 /pmc/articles/PMC4431465/ /pubmed/25974282 http://dx.doi.org/10.1038/srep10241 Text en Copyright © 2015, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Coburn, Bryan Wang, Pauline W. Diaz Caballero, Julio Clark, Shawn T. Brahma, Vijaya Donaldson, Sylva Zhang, Yu Surendra, Anu Gong, Yunchen Elizabeth Tullis, D. Yau, Yvonne C. W. Waters, Valerie J. Hwang, David M. Guttman, David S. Lung microbiota across age and disease stage in cystic fibrosis |
title | Lung microbiota across age and disease stage in cystic fibrosis |
title_full | Lung microbiota across age and disease stage in cystic fibrosis |
title_fullStr | Lung microbiota across age and disease stage in cystic fibrosis |
title_full_unstemmed | Lung microbiota across age and disease stage in cystic fibrosis |
title_short | Lung microbiota across age and disease stage in cystic fibrosis |
title_sort | lung microbiota across age and disease stage in cystic fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431465/ https://www.ncbi.nlm.nih.gov/pubmed/25974282 http://dx.doi.org/10.1038/srep10241 |
work_keys_str_mv | AT coburnbryan lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT wangpaulinew lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT diazcaballerojulio lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT clarkshawnt lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT brahmavijaya lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT donaldsonsylva lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT zhangyu lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT surendraanu lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT gongyunchen lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT elizabethtullisd lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT yauyvonnecw lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT watersvaleriej lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT hwangdavidm lungmicrobiotaacrossageanddiseasestageincysticfibrosis AT guttmandavids lungmicrobiotaacrossageanddiseasestageincysticfibrosis |